ATE245659T1 - Insulinabkömmlinge - Google Patents

Insulinabkömmlinge

Info

Publication number
ATE245659T1
ATE245659T1 AT96905764T AT96905764T ATE245659T1 AT E245659 T1 ATE245659 T1 AT E245659T1 AT 96905764 T AT96905764 T AT 96905764T AT 96905764 T AT96905764 T AT 96905764T AT E245659 T1 ATE245659 T1 AT E245659T1
Authority
AT
Austria
Prior art keywords
insulin derivatives
group
chain
amino acid
terminal amino
Prior art date
Application number
AT96905764T
Other languages
English (en)
Inventor
Jan Markussen
Ib Jonassen
Svend Havelund
Jakob Brandt
Peter Kurtzhals
Per Hertz Hansen
Niels Christian Kaarsholm
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE245659T1 publication Critical patent/ATE245659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96905764T 1995-03-17 1996-03-18 Insulinabkömmlinge ATE245659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK27695 1995-03-17
PCT/DK1996/000107 WO1996029344A1 (en) 1995-03-17 1996-03-18 Insulin derivatives

Publications (1)

Publication Number Publication Date
ATE245659T1 true ATE245659T1 (de) 2003-08-15

Family

ID=8091725

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905764T ATE245659T1 (de) 1995-03-17 1996-03-18 Insulinabkömmlinge

Country Status (14)

Country Link
EP (1) EP0871665B1 (de)
JP (1) JP3872105B2 (de)
KR (1) KR19980703039A (de)
CN (1) CN1196061A (de)
AT (1) ATE245659T1 (de)
AU (1) AU720966B2 (de)
BR (1) BR9607647A (de)
CA (1) CA2215694A1 (de)
CZ (1) CZ289343B6 (de)
DE (1) DE69629210T2 (de)
HU (1) HUP9800523A3 (de)
NO (1) NO974270L (de)
PL (1) PL183698B1 (de)
WO (1) WO1996029344A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693609A (en) * 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
US6451970B1 (en) * 1996-02-21 2002-09-17 Novo Nordisk A/S Peptide derivatives
US6268343B1 (en) 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
US7235627B2 (en) 1996-08-30 2007-06-26 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
HUP0004169A3 (en) * 1997-10-24 2001-06-28 Lilly Co Eli Insoluble insulin compositions and process for production thereof
CO4970787A1 (es) 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
AU776910B2 (en) * 1998-12-08 2004-09-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Modifying protein immunogenicity
TWI242000B (en) * 1998-12-10 2005-10-21 Univ Southern California Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
WO2003094956A1 (en) 2002-05-07 2003-11-20 Novo Nordisk A/S Soluble formulations comprising monomeric insulin and acylated insulin
CN1247616C (zh) * 2002-07-19 2006-03-29 上海中科生龙达生物技术(集团)有限公司 新的单体胰岛素,药物组合物及其制法
AU2004261353B2 (en) 2003-08-05 2009-12-10 Novo Nordisk A/S Novel insulin derivatives
EP1687428A1 (de) 2003-11-14 2006-08-09 Novo Nordisk A/S Verfahren zur herstellung von acyliertem insulin
EP2033662B1 (de) 2004-01-21 2012-10-17 Novo Nordisk Health Care AG Transglutaminase vermittelte konjugation von peptiden.
DK2060266T3 (da) 2004-03-17 2011-11-14 7Tm Pharma As Y4-selektiv receptoragonist PP2-36 til terapeutiske indgreb
EP2272524A3 (de) 2004-03-17 2011-02-02 7TM Pharma A/S Y2-selektive Rezeptor Agonisten und ihre therapeutische Verwendung
WO2006082204A1 (en) 2005-02-02 2006-08-10 Novo Nordisk A/S Insulin derivatives
ES2435522T3 (es) 2005-02-02 2013-12-20 Novo Nordisk A/S Derivados de insulina
EP1969004B1 (de) 2005-12-28 2011-08-10 Novo Nordisk A/S Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen
JP5202338B2 (ja) 2006-02-27 2013-06-05 ノボ・ノルデイスク・エー/エス 新規インシュリン誘導体
AU2007247109B2 (en) * 2006-05-09 2012-03-15 Novo Nordisk A/S Insulin derivative
CN101573133B (zh) 2006-07-31 2014-08-27 诺沃-诺迪斯克有限公司 Peg化延长的胰岛素
CN101541830A (zh) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
WO2008132224A2 (en) 2007-04-30 2008-11-06 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
JP5552046B2 (ja) 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー/エス インスリン誘導体を含有する薬学的製剤
ES2543393T3 (es) * 2007-11-08 2015-08-18 Novo Nordisk A/S Derivado de insulina
EP2058330A1 (de) * 2007-11-08 2009-05-13 Novo Nordisk A/S Insulinderivat
CN101970477B (zh) * 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 蛋白酶稳定的胰岛素类似物
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
CN102202683A (zh) 2008-10-30 2011-09-28 诺沃-诺迪斯克有限公司 用少于每日一次的注射频率注射胰岛素来治疗糖尿病
DK2632478T3 (da) 2010-10-27 2019-10-07 Novo Nordisk As Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
EP2836508B1 (de) 2012-04-11 2016-06-29 Novo Nordisk A/S Insulinformulierungen
EP2991672A1 (de) 2013-04-30 2016-03-09 Novo Nordisk A/S Neuartiges verabreichungsschema
CA2926701A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
BR112020002804A2 (pt) 2017-08-24 2020-07-28 Novo Nordisk A/S composição farmacêutica líquida, e, kit
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
TW202039437A (zh) 2018-12-11 2020-11-01 法商賽諾菲公司 肽黏合劑
CN114096269B (zh) 2019-07-12 2024-06-11 诺和诺德股份有限公司 高浓度胰岛素制剂
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK155690D0 (da) * 1990-06-28 1990-06-28 Novo Nordisk As Nye peptider
NZ273285A (en) * 1993-09-17 1997-10-24 Novo Nordisk As Insulin derivatives and compositions thereof

Also Published As

Publication number Publication date
DE69629210D1 (de) 2003-08-28
PL183698B1 (pl) 2002-06-28
KR19980703039A (ko) 1998-09-05
PL322299A1 (en) 1998-01-19
HUP9800523A2 (hu) 1998-06-29
WO1996029344A1 (en) 1996-09-26
JP3872105B2 (ja) 2007-01-24
NO974270D0 (no) 1997-09-16
CA2215694A1 (en) 1996-09-26
MX9707056A (es) 1997-11-29
CZ289997A3 (cs) 1998-01-14
CZ289343B6 (cs) 2002-01-16
HUP9800523A3 (en) 1998-09-28
NO974270L (no) 1997-11-14
DE69629210T2 (de) 2004-04-22
BR9607647A (pt) 1999-04-06
JPH11502110A (ja) 1999-02-23
AU720966B2 (en) 2000-06-22
AU4939696A (en) 1996-10-08
EP0871665B1 (de) 2003-07-23
CN1196061A (zh) 1998-10-14
EP0871665A1 (de) 1998-10-21

Similar Documents

Publication Publication Date Title
DE69629210D1 (de) Insulinabkömmlinge
MXPA97007050A (es) Derivados de hormona pepticida lipofilica.
ES2169251T3 (es) Peptidos de somatostatina.
GB9108652D0 (en) Immunoreactive compounds
DE60045524D1 (de) Ein Huhn GnRH-II Analog zur Verwendung in der Reduktion des Tumorzellwachstums
NO912438L (no) Humaninsulinanaloger.
PL312989A1 (en) Therapeutic derivatives of peptides
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
ATE113063T1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
ATE171712T1 (de) Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten
FI961044A0 (fi) Kininogeeni-inhibiittorit
IT1212508B (it) Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
ATE481420T1 (de) Il-21-derivate
MX9709962A (es) Peptidos de somatostatina.
DE69518246D1 (de) Aminosäuren konjugaten
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
ES2054942T3 (es) Procedimiento para la determinacion de fructuosaminas.
AU1993201A (en) Nucleic acid sequences of hyperplasia and tumours of the thyroid
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
ECSP961798A (es) Peptidos de somatostatina
DK119391A (da) Humaninsulinanaloger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties